These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 24817969)
21. TIGAR inclusion pathology is specific for Lewy body diseases. López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647 [TBL] [Abstract][Full Text] [Related]
22. Gastrointestinal nervous system α-synuclein as a potential biomarker of Parkinson disease. Yan F; Chen Y; Li M; Wang Y; Zhang W; Chen X; Ye Q Medicine (Baltimore); 2018 Jul; 97(28):e11337. PubMed ID: 29995769 [TBL] [Abstract][Full Text] [Related]
23. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. Marui W; Iseki E; Nakai T; Miura S; Kato M; Uéda K; Kosaka K J Neurol Sci; 2002 Mar; 195(2):153-9. PubMed ID: 11897247 [TBL] [Abstract][Full Text] [Related]
24. α-Synuclein pathology in the cranial and spinal nerves in Lewy body disease. Nakamura K; Mori F; Tanji K; Miki Y; Toyoshima Y; Kakita A; Takahashi H; Yamada M; Wakabayashi K Neuropathology; 2016 Jun; 36(3):262-9. PubMed ID: 26563477 [TBL] [Abstract][Full Text] [Related]
25. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Gelpi E; Navarro-Otano J; Tolosa E; Gaig C; Compta Y; Rey MJ; Martí MJ; Hernández I; Valldeoriola F; Reñé R; Ribalta T Mov Disord; 2014 Jul; 29(8):1010-8. PubMed ID: 24395122 [TBL] [Abstract][Full Text] [Related]
26. Distribution of proteinase K-resistant anti-α-synuclein immunoreactive axons in the cardiac plexus is unbiased to the left ventricular anterior wall. Fukasawa N; Maeda M; Sugiyama Y; Fukuda T; Shimoda M Pathol Int; 2024 Jan; 74(1):1-12. PubMed ID: 38038140 [TBL] [Abstract][Full Text] [Related]
27. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies]. Orimo S Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627 [TBL] [Abstract][Full Text] [Related]
28. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease. Del Tredici K; Hawkes CH; Ghebremedhin E; Braak H Acta Neuropathol; 2010 Jun; 119(6):703-13. PubMed ID: 20229352 [TBL] [Abstract][Full Text] [Related]
29. The Mechanisms of the Roles of α-Synuclein, Amyloid-β, and Tau Protein in the Lewy Body Diseases: Pathogenesis, Early Detection, and Therapeutics. Noguchi-Shinohara M; Ono K Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373401 [TBL] [Abstract][Full Text] [Related]
30. Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. Uchikado H; Lin WL; DeLucia MW; Dickson DW J Neuropathol Exp Neurol; 2006 Jul; 65(7):685-97. PubMed ID: 16825955 [TBL] [Abstract][Full Text] [Related]
31. Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene. Yamaguchi K; Cochran EJ; Murrell JR; Polymeropoulos MH; Shannon KM; Crowther RA; Goedert M; Ghetti B Acta Neuropathol; 2005 Sep; 110(3):298-305. PubMed ID: 15981014 [TBL] [Abstract][Full Text] [Related]
32. Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss. Annerino DM; Arshad S; Taylor GM; Adler CH; Beach TG; Greene JG Acta Neuropathol; 2012 Nov; 124(5):665-80. PubMed ID: 22941241 [TBL] [Abstract][Full Text] [Related]
33. Systematic review of genetic association studies in people with Lewy body dementia. Sanghvi H; Singh R; Morrin H; Rajkumar AP Int J Geriatr Psychiatry; 2020 May; 35(5):436-448. PubMed ID: 31898332 [TBL] [Abstract][Full Text] [Related]
34. Selective expression of α-synuclein-immunoreactivity in vesicular acetylcholine transporter-immunoreactive axons in the guinea pig rectum and human colon. Sharrad DF; de Vries E; Brookes SJ J Comp Neurol; 2013 Feb; 521(3):657-76. PubMed ID: 22821666 [TBL] [Abstract][Full Text] [Related]
35. Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains. Walker DG; Lue LF; Adler CH; Shill HA; Caviness JN; Sabbagh MN; Akiyama H; Serrano GE; Sue LI; Beach TG; Exp Neurol; 2013 Feb; 240():190-204. PubMed ID: 23201181 [TBL] [Abstract][Full Text] [Related]
36. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Beach TG; Adler CH; Sue LI; Vedders L; Lue L; White Iii CL; Akiyama H; Caviness JN; Shill HA; Sabbagh MN; Walker DG; Acta Neuropathol; 2010 Jun; 119(6):689-702. PubMed ID: 20306269 [TBL] [Abstract][Full Text] [Related]
37. Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Attems J; Toledo JB; Walker L; Gelpi E; Gentleman S; Halliday G; Hortobagyi T; Jellinger K; Kovacs GG; Lee EB; Love S; McAleese KE; Nelson PT; Neumann M; Parkkinen L; Polvikoski T; Sikorska B; Smith C; Grinberg LT; Thal DR; Trojanowski JQ; McKeith IG Acta Neuropathol; 2021 Feb; 141(2):159-172. PubMed ID: 33399945 [TBL] [Abstract][Full Text] [Related]
38. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Jellinger KA Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530 [TBL] [Abstract][Full Text] [Related]
39. Formation and development of Lewy pathology: a critical update. Jellinger KA J Neurol; 2009 Aug; 256 Suppl 3():270-9. PubMed ID: 19711116 [TBL] [Abstract][Full Text] [Related]
40. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]